IPO Trending
TATVAEQ / NSE, BSEListed

Tatva Chintan Pharma Chem Limited

Incorporated in 1996, Tatva Chintan Pharma Chem Limited is a specialty chemical manufacturer engaged in producing structure directing agents, phase transfer catalysts, pharmaceutical and agrochemical intermediates, and other specialty chemicals, and is among the largest producers of SDAs for zeolites in India. The company caters to a wide range of industries including automotive, petroleum, agrochemicals, dyes and pigments, paints and coatings, pharmaceuticals, personal care, and others, with products sold in India and exported to over 25 countries such as the USA, Germany, South Africa, China, and the UK. Exports contributed around 76% of its revenue in FY 2020, and its customer base includes leading names like Merck, Bayer AG, Laurus Labs, Navin Fluorine, Atul Limited, SRF Limited, and Divi’s Laboratories, with manufacturing facilities located at Ankleshwar and Dahej in Gujarat.

₹1,073 - ₹1,083Open
Listed Price2111.85
Listing Gain+95.00%
Subscription0x total demandUpdated 23 Dec 2025, 12:19 PM
Subscription PendingExchange subscription breakup is not available yet.

Category-wise demand has not been published yet. Check back after the exchange updates the live subscription feed.

Open Date16 Jul 2021
Close Date20 Jul 2021
Listing Date29 Jul 2021